LinkedIn Logo

February 20-22, 2018

Boston, USA

With an exclusive focus on empowering translational neurodegenerative research, the 6th Annual World CNS Summit remains the only industry-specific conference to help bridge the gap for translational development.

Bringing together over 100 senior scientists and executives from across biopharma and academia, join us to challenge traditional thinking in the development of efficacious treatments against neurodegeneration.

This is a unique opportunity to engage with the leading minds in the neurodegenerative space from academia, pharma, biotech and leading consortia to advance the successful development of the next generation of therapies.

What’s new for this year?

  • Greater focus on alternative aetiologies of disease including neuroinflammation, microglial activation and lysosomal dysfunction
  • Increased attention on R&D technologies to effectively identify novel targets and candidate therapeutics
  • More preclinical case studies exploring means to improve the translatability of pre-clinical models
  • Strategies to validate clinically relevant biomarkers to inform translational research programmes and improve the success of clinical studies

Find Out More | Register Your Interest

“Every speaker was excellent. A very informative and thought provoking series of presentations.”

National Institute Neurologic Disease and Stroke

"A great meeting. The networking opportunities were fantastic."

Pfizer

"I liked the breadth of commercial development (pre-clinical up through clinical) included in the program. The meeting is a must go for anyone seriously considering drug development."

St. Lawrence University

Who Attends?
Widget- Who Attended 200px